Burjeel’s $1.5 billion sukuk plan puts UAE hospital expansion in focus

Burjeel Holdings has opened a $1.5 billion sukuk programme in London, giving the Abu Dhabi hospital group a repeatable funding route for specialist care, AI services and expansion.

For healthcare CEOs and CFOs, the number to watch is $1.5 billion: it gives Burjeel Holdings optional capital while UAE providers compete for patients, clinicians and higher-acuity services. The programme also puts a public credit benchmark around Burjeel as peers including PureHealth and NMC Healthcare remain part of the UAE consolidation story.

What Burjeel is raising

The Sharia-compliant programme was set up through Burjeel Sukuk Limited and admitted to the London Stock Exchange International Securities Market, according to Gulf News on 22 June 2026. Burjeel said it had started discussions with regional and international fixed-income investors on a possible first five-year senior unsecured sukuk issue.

"Receiving first-time ratings from two of the world's leading credit rating agencies is an important milestone for Burjeel Holdings." Dr. Shamsheer Vayalil, Chairman and CEO, Burjeel Holdings

S&P Global Ratings assigned Burjeel Holdings a BB+ issuer credit rating with a stable outlook. Moody's Ratings assigned a Ba2 corporate family rating with a stable outlook. Burjeel said any issuance depends on market conditions, regulatory approvals and offering documents.

Why operators should care

The announcement matters most to executives who track funding capacity in the UAE provider market. Burjeel Holdings says proceeds may support specialist medical care, research, medical education, digital projects and AI-based healthcare services. Those priorities point to service-line expansion rather than a single new hospital opening.

• $1.5 billion total sukuk programme size
• Five-year potential first senior unsecured sukuk issue
• BB+ rating from S&P Global Ratings
• Ba2 rating from Moody's Ratings
• 5 stated funding priorities, including specialist care and AI-based healthcare services

For CFOs, the issue is pricing and debt capacity. A first sukuk sale would put Burjeel Holdings in front of international fixed-income investors, giving lenders and competitors a clearer market view of its balance sheet. It would also test investor demand for UAE healthcare credit at a time when providers are spending on specialists, digital systems and capacity.

COOs should treat the programme as a medium-term capacity signal. In Abu Dhabi, facility licensing, new clinical activities and professional licensing remain under the Department of Health - Abu Dhabi (DOH). Expansion in Dubai would involve the Dubai Health Authority (DHA), while Northern Emirates facilities would fall under the Ministry of Health and Prevention (MOHAP).

Market context

The funding plan comes after stronger first-half activity at Burjeel Holdings. Gulf News reported on 6 August 2026 that Burjeel treated more than 3.7 million patients in the first half of 2026. Net profit excluding one-off items reached AED 227 million, while revenue rose 4.4% year on year to AED 2.79 billion.

Those results show why funding flexibility matters. Patient visits rose 9.9% in the first half of 2026, and operating cash flow increased 76.8% to AED 405 million. Hospitals generated AED 2.5 billion in first-half revenue, equal to 89% of group revenue. That concentration makes hospital throughput, medical workforce availability and payer mix central to Burjeel's margin story.

The concrete takeaway for executives is the first drawdown under the $1.5 billion programme. A large or tightly priced issue would give Burjeel Holdings more room in expansion talks. A delayed issue would show that rate conditions still limit healthcare balance sheets, even for large UAE groups with public ratings and rising patient volumes.